CPC C12N 15/113 (2013.01) [A61P 13/02 (2018.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/3231 (2013.01); C12N 2310/3341 (2013.01); C12N 2310/341 (2013.01); C12N 2310/346 (2013.01); C12N 2320/32 (2013.01); C12N 2320/35 (2013.01)] | 12 Claims |
1. A method of treating, preventing, or ameliorating a kidney disease associated with APOL1 in an individual comprising administering to the individual a compound according to the following formula (SEQ ID NO: 1950):
![]() or a pharmaceutically acceptable salt thereof, thereby treating, preventing, or ameliorating the disease.
|